BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» Zealand Pharma presents preclinical data on GIP analogue ZP-6590
To read the full story,
subscribe
or
sign in
.
Endocrine/Metabolic
Zealand Pharma presents preclinical data on GIP analogue ZP-6590
Nov. 9, 2022
Researchers from Zealand Pharma A/S have presented details on their investigation of ZP-6590 as an antiobesity and antiemetic drug in mice.
BioWorld Science
Conferences
Endocrine/metabolic
